Table 3.

Comparison of Hs-TnI and CK-MB in 2 groups.

Time	Hs-TnI (µg/L)		T value	P value	CK-MB (U/L)		T value	P value	MYO (µg/L)		T value	P value
	Experimental group (n = 62)	Control group (n = 62)			Experimental group (n = 62)	Control group (n = 62)			Experimental group (n = 62)	Control group (n = 62)
Pretreatment	1.27 ± 0.54	1.26 ± 0.61	0.144	0.886	9.88 ± 2.17	9.86 ± 2.21	0.089	0.929	121.96 ± 11.56	121.88 ± 10.89	0.012	0.845
1 day after treatment	1.26 ± 0.41	1.25 ± 0.78	0.066	0.948	9.91 ± 2.22	9.89 ± 2.31	0.073	0.942	87.09 ± 8.91*	88.31 ± 9.21*	0.045	0.758
3 days after treatment	0.75 ± 0.33*	0.99 ± 0.37*	-4.113	<0.001	6.76 ± 2.01*	8.03 ± 2.40*	-4.024	<0.001	60.12 ± 8.11*	65.32 ± 9.11*	-4.331	<0.001
7 days after treatment	0.41 ± 0.28*	0.58 ± 0.43*	-1.379	0.170	3.81 ± 1.81*	6.11 ± 1.98*	-5.697	<0.001	32.16 ± 7.12*	36.13 ± 6.97*	-4.132	<0.001

CK-MB = creatine kinase-MB, hs-TnI = high-sensitivity troponin I, MYO = myocardial enzyme levels.

^* There were significant differences in the group compared with before treatment (P < .05).